Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good point, very likely. Might aim for .75 short term target and see if I hit it.
Crazy Strong Trading, impressed. Non-iHub money pouring in imo
Looks like a straight to .50 run inbound to me
Seriously what's going on here, once we break .10 then we trade in .01 increments within minutes... .50 coming before June ?
Who's buying this? We keep climbing without much ihub investors it seems.
Bring on the news please!
Today or Tomorrow for the big reveal gonna be a fun journey.
From October last year.
Patient Access Solutions Inc. Names Two Members to Board of Advisors
GlobeNewswire GlobeNewswireOctober 31, 2019
COMMACK, NY, Oct. 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Patient Access Solutions, Inc. (OTC PINK: PASO), is pleased to announce that it has appointed Jon McBride, Chief Technical Officer for Integrated Health Association (IHA) based in San Francisco, CA, and Jarvis Shockey, Senior Vice President for VPay, Inc based in Dallas, TX, to its Board of Advisors effective December 1, 2019.
About Joseph Gonzalez
Gonzalez, 48, Chief Executive Officer (CEO) for Sunfish Health since 2014. Sunfish Health is a Clinical Data exchange focused on mining and normalization of clinical information for use by Health Insurance Companies. For over 18 years Mr. Gonzalez has developed and/or advised with the nation's leading companies in the financial, healthcare, and clinical data verticals. During that period, he Co-Founded Inmediata in 2004, a Puerto Rico based Healthcare clearinghouse, and led their US Mainland expansion initiative under the Secure EDI brand. His team was responsible for growing Inmediata from a start up to a topline of $30M. Inmediata was sold to private equity for $90M in 2013. Joseph has been professionally engaged in the industry by holding leadership roles with standards developing organizations. From 2010-2015 he served as member of the Cooperative Exchange, the US Association of Health IT companies, Executive Committee and Board of Directors. From 2012 to 2015 he served as its President and Chairman. He has also held the positions of Vice Chairman and Board of Directors Trustee to the NCPDP/NDEDIC. Joseph has Chaired or co-chaired committees and workgroups within ASC X12, Workgroup for Electronic Data Interchange (WEDI), Center for Affordable Quality Healthcare's CORE initiative and the Electronic Healthcare Network Accreditation Commission (EHNAC). Joseph has been a featured speaker on 4010/5010 transaction transition, Innovations in Healthcare Payments and Electronic Remittance, and testified before Health and Human Services (Center for Medicare Services), U.S. Congressional Health Data Advisory Sub Committee. Additionally, he has been a featured participant in Healthcare Informatics Round table events hosted by the Robert W Johnson Foundation and authored white papers on Clinical Data & Electronic Medical Record strategies and solutions. Mr. Gonzalez holds a BA in Political Science from the United States Naval Academy.
0.50+ very soon imo
I like how this is trading - churning and resetting rsi with every move up, very nice way to .10
Monster in the making written all over it
We were above .10 last march - come on folks
2.40 short term Target I'm good with that. If buyout comes raise to 5.00 or 10.00 ?
This is heating up in a big way - looking at multi-day runner here.
That's huge. Seeing big things coming here for sure.
It's gonna be glorious this week, once everyone learns what we have here. Skyward is the only way forward.
Expecting merger reveal news next week hopefully we'll see .25+ based on that excitement.
.60+ upon merger completion in June imo
MONSTER move After Hours?
I haven't sold any and I got in at 3.19 and 3.41. Still pondering about where to take profits. Thinking 40% around $7, 30% at $8 and finish off with another 30% near $10.
I got in at 3.19 and 3.41, had it set to sell at 4.99 but I didn't know you can't trade during after hours with my broker (RBC Direct Investing)
So I am stuck in this
Wow Amazon is hiring TLSS drivers at their warehouses - that is huge. $2.67 with buyout here.
Wow over $1.6 Million in trading volume so far today - gonna be absolutely massive here.
That's huge - looking to be trading in dimes here very soon. I''m seeing whales entering right now.
SMA200 @ 2.90
Potential Amazon buyout price $2.67
No coincidences.
Coiling hard here - get ready for another MASSIVE breakout.
We should break last months highs of .12 with $100 million expected
This looks like it's going to be an amazing trading day - especially with update that OTCMarkets fees we're just paid should be seeing filings drop any time now.
I think it's reasonable to assume 20 bagger from here. I'm aiming for .70
#7 on Most Read board - Tons of new eyes on this in time for Monday. I see a very nice open coming Monday morning!
This one has the look of a silver mover imo
10K News tomorrow pre-market. We open at .10+ drive up to .25 during day.
HUGE: Peer Reviewed Publication: CAP-1002 in Critically Ill Patients – Compassionate Use Case Series (May 2020) Publication Here
http://www.globenewswire.com/news-release/2020/05/14/2033829/0/en/Capricor-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html
Duchenne Muscular Dystrophy Program
-Final Top-Line 12-month Results from Phase II Randomized, Double-blind, Placebo-controlled HOPE-2- Study Demonstrated Improved Performance of Upper Limb (PUL) 2.0 (p=0.05)-
COVID-19 Program
-COVID-19 Compassionate Use Case Series Published in Peer Reviewed Journal-
-Reported 100 Percent Survival in Critical COVID-19 Patients Treated with CAP-1002 Under Compassionate Use Pathway-
-Expanded Access Protocol Approved by FDA to Treat Critical COVID-19 Patients-
-Appointed Stephen J. Gould, Ph.D. to lead Capricor’s Exosome-Based Platform Vaccine Approach Against COVID-19-
-To Host Conference Call and Webcast Today at 4:30 p.m. ET-
The company has initiated a technology transfer with a global contract manufacturing organization (CMO) to prepare for commercial production.
Power hour about to start watch and learn, I know how locked up this is.
#17 Most Read and #8 in the last hour. We are peaking at the right time just before 10K hits, going to be a rocket ship.
Won't take much to hit .15 again today - May even see it power hour shortly imo
The more they pull it down the bigger the short squeeze when successful trial news hits.
With the 10K almost here we will rocket power hour imo open tomorrow at .20
Aim for .30 tomorrow doesn't get any bigger 10K that's about to drop